Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice

Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats

(2017) Erin M. Rock et al.   PSYCHOPHARMACOLOGY

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors

(2016) A.G. Sartim et al.   BEHAVIOURAL BRAIN RESEARCH

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Cannabidiol, neuroprotection and neuropsychiatric disorders

(2016) Alline C. Campos et al.   PHARMACOLOGICAL RESEARCH

Experimental design and analysis and their reporting: new guidance for publication in BJP

(2015) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

(2015) John C McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Evaluation of sex differences in cannabinoid dependence

(2014) Julie A. Marusich et al.   DRUG AND ALCOHOL DEPENDENCE

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1Areceptors without diminishing nervous system function or chemotherapy efficacy

(2013) Sara Jane Ward et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of Early Chemotherapeutic Treatment on Learning in Adolescent Mice: Implications for Cognitive Impairment and Remediation in Childhood Cancer Survivors

(2013) E. B. Bisen-Hersh et al.   CLINICAL CANCER RESEARCH

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience

(2013) M.V. Fogaça et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Marijuana Dependence: Not Just Smoke and Mirrors

(2013) D. Ramesh et al.   ILAR JOURNAL

Δ9Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques

(2013) M.J. Wright et al.   NEUROSCIENCE

Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function

(2012) Matthijs G. Bossong et al.   BIOLOGICAL PSYCHIATRY

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

(2012) Amir Englund et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences

(2012) Natania A. Crane et al.   NEUROPSYCHOLOGY REVIEW

Disruptive effects of the prototypical cannabinoid Δ9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats

(2011) Ljiljana Sokolic et al.   BEHAVIOURAL PHARMACOLOGY

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

(2011) Ethan B Russo   BRITISH JOURNAL OF PHARMACOLOGY

The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress

(2011) David J. Allsop et al.   DRUG AND ALCOHOL DEPENDENCE

Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum

(2011) Pablo Pandolfo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats

(2011) Charlotte Klein et al.   PSYCHOPHARMACOLOGY

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

(2010) Plinio C. Casarotto et al.   BEHAVIOURAL PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

(2010) José Alexandre S Crippa et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze

(2010) Peng Huang et al.   NEUROSCIENCE LETTERS

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

(2010) Felipe V. Gomes et al.   PSYCHOPHARMACOLOGY

Hippocampal CB1 Receptors Mediate the Memory Impairing Effects of Δ9-Tetrahydrocannabinol

(2009) Laura E Wise et al.   NEUROPSYCHOPHARMACOLOGY

Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice

(2009) Peng Huang et al.   NEUROSCIENCE LETTERS

Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats

(2009) Sara Jane Ward et al.   PSYCHOPHARMACOLOGY

Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor

(2008) Ziva D. Cooper et al.   ADDICTION BIOLOGY

Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism

(2007) Kazuhide Hayakawa et al.   BRAIN RESEARCH

Adenosine A2A receptor blockade prevents memory dysfunction caused by β-amyloid peptides but not by scopolamine or MK-801

(2007) Geanne M.A. Cunha et al.   EXPERIMENTAL NEUROLOGY